184 related articles for article (PubMed ID: 37009577)
21. Shaves off the Cavity or Specimen in Lumpectomy for Breast Cancer.
Iwai Y; Prigoff JG; Sun L; Wiechmann L; Taback B; Rao R; Ugras SK
J Surg Res; 2022 Sep; 277():296-302. PubMed ID: 35526391
[TBL] [Abstract][Full Text] [Related]
22. Role of specimen US for predicting resection margin status in breast conserving therapy.
Moschetta M; Telegrafo M; Introna T; Coi L; Rella L; Ranieri V; Cirili A; Stabile Ianora AA; Angelelli G
G Chir; 2015; 36(5):201-4. PubMed ID: 26712255
[TBL] [Abstract][Full Text] [Related]
23. Routine cavity shaves following breast conserving surgery; friend or foe?
Monib S; Anis K; Habashy H
Surg Oncol; 2021 Jun; 37():101521. PubMed ID: 33548588
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic Accuracy of Quantitative Micro-Elastography for Margin Assessment in Breast-Conserving Surgery.
Kennedy KM; Zilkens R; Allen WM; Foo KY; Fang Q; Chin L; Sanderson RW; Anstie J; Wijesinghe P; Curatolo A; Tan HEI; Morin N; Kunjuraman B; Yeomans C; Chin SL; DeJong H; Giles K; Dessauvagie BF; Latham B; Saunders CM; Kennedy BF
Cancer Res; 2020 Apr; 80(8):1773-1783. PubMed ID: 32295783
[TBL] [Abstract][Full Text] [Related]
25. Long-term Results After Oncoplastic Surgery for Breast Cancer: A 10-year Follow-up.
Clough KB; van la Parra RFD; Thygesen HH; Levy E; Russ E; Halabi NM; Sarfati I; Nos C
Ann Surg; 2018 Jul; 268(1):165-171. PubMed ID: 28448389
[TBL] [Abstract][Full Text] [Related]
26. Surgical management of lobular carcinoma from a national screening program: a retrospective analysis.
Sharma SD; Barry M; O'Reilly EA; Kell MR
Eur J Surg Oncol; 2015 Jan; 41(1):79-85. PubMed ID: 25441933
[TBL] [Abstract][Full Text] [Related]
27. Do All Positive Margins in Breast Cancer Patients Undergoing a Partial Mastectomy Need to Be Resected?
Chagpar AB; Tsangaris TN; Lannin DR
J Am Coll Surg; 2018 Jul; 227(1):13-21. PubMed ID: 29524664
[TBL] [Abstract][Full Text] [Related]
28. Real-time Visualization of Breast Carcinoma in Pathology Specimens From Patients Receiving Fluorescent Tumor-Marking Agent Tozuleristide.
Dintzis SM; Hansen S; Harrington KM; Tan LC; Miller DM; Ishak L; Parrish-Novak J; Kittle D; Perry J; Gombotz C; Fortney T; Porenta S; Hales L; Calhoun KE; Anderson BO; Javid SH; Byrd DR
Arch Pathol Lab Med; 2019 Sep; 143(9):1076-1083. PubMed ID: 30550350
[TBL] [Abstract][Full Text] [Related]
29. Low re-excision rate for positive margins in patients treated with ultrasound-guided breast-conserving surgery.
Yu CC; Chiang KC; Kuo WL; Shen SC; Lo YF; Chen SC
Breast; 2013 Oct; 22(5):698-702. PubMed ID: 23333255
[TBL] [Abstract][Full Text] [Related]
30. The effect of introducing an in-theatre intra-operative specimen radiography (IOSR) system on the management of palpable breast cancer within a single unit.
Layfield DM; May DJ; Cutress RI; Richardson C; Agrawal A; Wise M; Yiangou C
Breast; 2012 Aug; 21(4):459-63. PubMed ID: 22119488
[TBL] [Abstract][Full Text] [Related]
31. Does intra-operative margin assessment improve margin status and re-excision rates? A population-based analysis of outcomes in breast-conserving surgery for ductal carcinoma in situ.
Laws A; Brar MS; Bouchard-Fortier A; Leong B; Quan ML
J Surg Oncol; 2018 Dec; 118(7):1205-1211. PubMed ID: 30293241
[TBL] [Abstract][Full Text] [Related]
32. The influence of additional surgical margins on the total specimen volume excised and the reoperative rate after breast-conserving surgery.
Huston TL; Pigalarga R; Osborne MP; Tousimis E
Am J Surg; 2006 Oct; 192(4):509-12. PubMed ID: 16978962
[TBL] [Abstract][Full Text] [Related]
33. Identifying Factors and Techniques to Decrease the Positive Margin Rate in Partial Mastectomies: Have We Missed the Mark?
Edwards SB; Leitman IM; Wengrofsky AJ; Giddins MJ; Harris E; Mills CB; Fukuhara S; Cassaro S
Breast J; 2016 May; 22(3):303-9. PubMed ID: 26854189
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of surgically excised breast tissue microstructure using wide-field optical coherence tomography.
Schmidt H; Connolly C; Jaffer S; Oza T; Weltz CR; Port ER; Corben A
Breast J; 2020 May; 26(5):917-923. PubMed ID: 31612563
[TBL] [Abstract][Full Text] [Related]
35. Predictors of re-excision among women undergoing breast-conserving surgery for cancer.
Waljee JF; Hu ES; Newman LA; Alderman AK
Ann Surg Oncol; 2008 May; 15(5):1297-303. PubMed ID: 18259820
[TBL] [Abstract][Full Text] [Related]
36. Role for intraoperative margin assessment in patients undergoing breast-conserving surgery.
Cabioglu N; Hunt KK; Sahin AA; Kuerer HM; Babiera GV; Singletary SE; Whitman GJ; Ross MI; Ames FC; Feig BW; Buchholz TA; Meric-Bernstam F
Ann Surg Oncol; 2007 Apr; 14(4):1458-71. PubMed ID: 17260108
[TBL] [Abstract][Full Text] [Related]
37. Involved margins after lumpectomy for breast cancer: Always to be re-excised?
Sorrentino L; Agozzino M; Albasini S; Bossi D; Mazzucchelli S; Vanna R; Papadopoulou O; Villani L; Corsi F
Surg Oncol; 2019 Sep; 30():141-146. PubMed ID: 31500779
[TBL] [Abstract][Full Text] [Related]
38. A two-millimetre free margin from invasive tumour minimises residual disease in breast-conserving surgery.
Ward ST; Jones BG; Jewkes AJ
Int J Clin Pract; 2010 Nov; 64(12):1675-80. PubMed ID: 20946273
[TBL] [Abstract][Full Text] [Related]
39. The safety of multiple re-excisions after lumpectomy for breast cancer.
Coopey S; Smith BL; Hanson S; Buckley J; Hughes KS; Gadd M; Specht MC
Ann Surg Oncol; 2011 Dec; 18(13):3797-801. PubMed ID: 21630123
[TBL] [Abstract][Full Text] [Related]
40. Optical tissue measurements of invasive carcinoma and ductal carcinoma in situ for surgical guidance.
de Boer LL; Kho E; Van de Vijver KK; Vranken Peeters MTFD; van Duijnhoven F; Hendriks BHW; Sterenborg HJCM; Ruers TJM
Breast Cancer Res; 2021 May; 23(1):59. PubMed ID: 34022928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
